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Abstract
Many livestock and human vaccines are leaky because they block symptoms but do not pre-
vent infection or onward transmission. This leakiness is concerning because it increases
vaccination coverage required to prevent disease spread and can promote evolution of
increased pathogen virulence. Despite leakiness, vaccination may reduce pathogen load,
affecting disease transmission dynamics. However, the impacts on post-transmission dis-
ease development and infectiousness in contact individuals are unknown. Here, we use
transmission experiments involving Marek disease virus (MDV) in chickens to show that
vaccination with a leaky vaccine substantially reduces viral load in both vaccinated individu-
als and unvaccinated contact individuals they infect. Consequently, contact birds are less
likely to develop disease symptoms or die, show less severe symptoms, and shed less
infectious virus themselves, when infected by vaccinated birds. These results highlight that
even partial vaccination with a leaky vaccine can have unforeseen positive consequences
in controlling the spread and symptoms of disease.
Introduction
Vaccination is routinely used as an efficient and economical way to control the spread and
symptoms of infectious diseases in humans and livestock. Vaccines vary in their protective
properties [1,2], and although some completely block infection, others only prevent disease
symptoms but not infection or onward transmission. The latter are termed ‘leaky’ or ‘imper-
fect’ vaccines. Leaky vaccines are commonly used to prevent or alleviate disease symptoms in
livestock and are becoming more prevalent among human vaccines [3]. Leakiness allows path-
ogen populations to persist even at high levels of vaccination coverage [4], and reduced mortal-
ity of vaccinated individuals can lengthen their infectious period and hence promote the
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evolution of increased pathogen virulence [5]. A better understanding of the overall impacts
on populations of vaccination with leaky vaccines is therefore urgently needed.
The underlying hypothesis in this paper is that vaccination with leaky vaccines not only has
direct positive effects on vaccinated individuals but also indirect positive effects on individuals
in the same contact group. Often only a fraction of a population receives the direct benefits of
vaccination because of incomplete coverage and heterogeneity in vaccine responses [6–8].
However, vaccination even with a leaky vaccine often reduces pathogen load in infected indi-
viduals [5,9–15], with potential consequent reduction in the exposure dose of susceptible indi-
viduals. Transmission experiments, in which infected ‘shedders’ are placed in contact with
uninfected ‘contact’ individuals and transmission recorded, have revealed that lower shedder
pathogen load reduces transmission in some cases [5,16,17] but not all [13]. Measures of vac-
cine effectiveness can include these indirect benefits for unvaccinated individuals through
dose-dependent reduction in transmission rates from infected vaccinated individuals [18].
However, beyond transmission effects, lower exposure dose can also decrease pathogen load in
newly infected hosts [19–21], potentially leading to decreased pathogen virulence [19–20,22–
27] and infectiousness in these secondary cases. These downstream effects of leaky vaccines on
disease development and spread are currently poorly understood. Here, we use transmission
experiments with vaccinated versus sham-vaccinated shedders and only unvaccinated contact
individuals to examine how a leaky vaccine affects both transmission and subsequent pathogen
virulence and load (and hence, potentially, infectiousness) in contacts.
Gallid alphaherpesvirus 2, more commonly referred to as Marek disease virus (MDV), is a
highly oncogenic herpesvirus of poultry causing worldwide annual losses of US$1 to US$2
billion [28]. It is an airborne pathogen, spreading via inhalation of virus-laden ‘chicken dust’,
which accumulates through shedding of infectious feather follicle epithelia [29]. Marek disease
(MD) symptoms include peripheral nerve enlargement, tumours in a variety of organs, wing
and leg paralysis, and iris lymphoma causing pupil irregularities, as well as death. Infected
birds remain infectious for life, and the virus can remain infectious in the environment for
many months. Higher MDV ingestion dose has been reported to increase disease progression
[27,30], but this effect has not previously been linked to vaccination or exposure dose under
natural transmission. On top of clear welfare concerns, MD causes production losses at inspec-
tion because of a drop in egg production of laying hens [31] and symptoms known as ‘leuko-
sis’, leading to meat condemnation. Leukosis has other causative agents but is primarily due to
MDV in chickens [32].
Management of MD led to development of the first widely used anti-cancer vaccine, the
related live turkey herpesvirus Meleagrid alphaherpesvirus 1, commonly referred to as herpes-
virus of turkeys (HVT) [33]. In the United States, vaccination of all commercial poultry has
been routine since the 1970s. However, from the 1950s to the present day, there have been
several jumps in MDV virulence [34], each causing more severe symptoms and reducing the
symptom-blocking effects of existing vaccines. Several generations of vaccines have been
developed to combat this increased virulence, all of which are leaky and may in fact have con-
tributed to continuing virulence evolution [5]. Currently, widespread vaccination leads to low
production losses in the US commercial poultry industry. However, vaccination is not routine
worldwide and may vary considerably in quantity and quality [35], leading to incomplete
effective vaccine coverage within a flock.
All MD vaccines including HVT are modified live viruses and are therefore potentially
transmissible. Whenever transmissible live vaccines are used, vaccine transmission itself can
potentially confer some secondary downstream protection in unvaccinated contacts, in addi-
tion to the effect of reduction in transmission of pathogenic virus. The more recently devel-
oped and widely used CVI988 (Rispens) MD vaccine is highly transmissible [36]. However,
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despite quite extensive shedding of HVT vaccine virus into the environment [37,38], HVT
transmission is usually low and is thought to be absent from young birds <8 weeks old vacci-
nated with low doses [39–41].
High variability in virulence among MDV strains [42], in genetic resistance among chicken
strains [43], and in vaccine effectiveness [44] and transmissibility, combined with well-devel-
oped empirical methods for examining host infection and disease [45], make MDV in chickens
an ideal model system to examine the relationships between vaccination with leaky vaccines
and pathogen load, transmission, and subsequent virulence in unvaccinated birds.
The overall aim of this study was to assess how vaccination with a leaky vaccine affects path-
ogen transmission and subsequent disease development in unvaccinated contact individuals.
To investigate this, we carried out transmission experiments for MDV in chickens, in which
HVT-vaccinated or sham-vaccinated shedder birds inoculated with a virulent (vMDV) patho-
gen strain were placed in contact with unvaccinated naïve contact birds (Fig 1). We chose
HVT vaccine because of its low transmissibility, its wide usage both to combat MDV and as a
vector vaccine, and our extensive previous experience with this vaccine allowing optimization
of experimental methods. We chose to focus solely on a well-studied vMDV (rather than more
virulent vvMDV or vv+MDV) pathogen strain to allow comparison with many past studies
and to maximize replication and hence our ability to detect differences in downstream effects.
We used unvaccinated contacts to avoid confounding effects of vaccination on contact bird
resistance and shedder transmission ability. We investigated to what extent vaccination
reduces both MDV transmission and subsequent disease severity in contacts and asked
whether the effects of shedder vaccination on contacts were mediated by lower shedder viral
load. We found that shedder vaccination led to a large reduction in contact bird disease
symptoms and provide strong evidence that this effect was mediated by pathogen load.
Results
Establishing the transmission model and sampling times
Unless otherwise stated, ‘transmission’, ‘virus’, and ‘viral load’ refer to the pathogenic MDV
strain and not the vaccine virus strain. Appropriate contact duration and sampling times to
examine shedder vaccination effects needed to be established in pilot experiments prior to the
main trial (S1 Text). As little as 4 hours of contact between inoculated shedders and uninfected
contacts was sufficient for most contact birds to become infected and show visible disease
symptoms by 8 weeks post-contact (S2 Text, S1 Fig). A contact duration of 2 days was subse-
quently chosen to ensure ample shedding time and to standardize time available for shedding
of feather follicle epithelia by the shedders. Both vaccinated and sham-vaccinated shedders
were positive for small quantities of virus in feather follicle epithelia by 7 days post-infection
(DPI), but this feather viral load (FVL) had increased considerably by 10 to 12 DPI (S3 Text,
S2 Fig). When shedders were moved to a new set of contacts every 2 days from 10 to 20 DPI,
the proportion of infected contacts, as measured by quantitative polymerase chain reaction
(qPCR) from feather and blood samples collected 14 days post-contact (DPC), was consistently
high (S3 Text, S3 Fig). However, although contact with sham-vaccinated shedders also consis-
tently led to high incidence of disease symptoms at necropsy, contact with vaccinated shedders
led to lower proportion of diseased contacts, in particular at the early contact periods. These
temporal trends coincided with differences in shedder FVL, with higher overall FVL in sham-
vaccinated birds, reaching a peak around 12 DPI and lower FVL peaking around 20 DPI in
vaccinated shedders (S2 Fig). Both groups of shedders then remained positive for virus in
feathers for the 8-week duration.
Vaccination and the transmission of pathogen virulence
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Informed by the pilot data, we chose 13 and 20 shedder DPI as standardized contact start
times in the main experiments (Fig 1) to capture the aforementioned temporal variation in
vaccine effects and a 2-day contact period between shedders and contacts. Fourteen DPC was
chosen as the time for contact bird blood and feather sampling, because it proved ample for
build-up of FVL in infected contacts while minimizing among-contact transmission (S4 Fig).
Viral loads were highly correlated between blood and feathers (main experiment contact birds
only, correlation coefficient r = 0.73) and were typically higher and more often above the
detection threshold in feathers, as shown previously [46]. Hence, we focused on viral load in
feathers for all analyses because of the dual benefits of the typically above-threshold level viral
loads and the fact that feathers are the infectious tissue, hence increasing the likely association
with infectiousness. Examination of the presence and severity of disease symptoms (tumours
and peripheral nerve enlargement) at necropsy took place at 8 weeks post-infection (shedders)
or post-contact (contacts), or when moribund, if this occurred earlier. The subsequent results
only refer to analyses of data from the main experiment illustrated in Fig 1.
Vaccination blocks shedder disease symptoms without blocking infection
As expected, all shedder birds were positive for MDV as determined by qPCR, and vaccination
almost universally blocked the development of disease symptoms at necropsy. Eighty out of
eighty-six sham-vaccinated shedders (93%; 4 out of 90 birds excluded because of early death
Fig 1. Schematic overview of one ‘lot’ (2 lots per replicate, 1 for each shedder vaccination status) of the MD transmission experiment. In each lot,
shedder birds were all either HVT-vaccinated or PBS sham-vaccinated. All contacts were unvaccinated. The experiment comprised 16 replicates, each
consisting of 1 lot in which 3 infected vaccinated shedders were placed in 48-hour contact with 15 naïve unvaccinated contacts at 2 time points, and 1
equivalent lot with sham-vaccinated shedders (4 additional sham-vaccinated lots were added because 2 of these had only 2 shedders because of early
death). In total, there were 1,080 contacts and 106 shedder individuals distributed into 72 contact bird groups. Contact bird groups each had roughly
equal numbers of males and females. All indicated time points (not to scale) are relative to the day of shedder inoculation with wild-type virus. Open
and closed symbols represent uninfected and infected chickens, respectively. For all birds, necropsy was carried out to determine the presence and
severity of disease symptoms (tumours and peripheral nerve enlargement) at 8 weeks post-infection (shedders) or post-contact (contact birds), or upon
death/euthanasia, whichever was the sooner. HVT, herpesvirus of turkeys; MD, Marek disease; PBS, phosphate buffer solution.
https://doi.org/10.1371/journal.pbio.3000619.g001
Vaccination and the transmission of pathogen virulence
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from other causes) were MD-positive at necropsy, whereas only 5 out of 80 (6%) vaccinated
shedders were MD positive.
Shedder vaccination does not block transmission but reduces contact bird
disease development and pathogen load
The complete set of contact bird analysis results are presented in S1 Table. Overall, vaccination
of shedders did not block virus transmission but dramatically reduced the negative impacts of
infection in contact birds. Almost all contacts became infected regardless of shedder vaccination
status or DPI, with 100% (all 572 birds) contact bird infection for sham-vaccinated shedders and
97.4% for vaccinated (442 out of 454). This difference, albeit small, was significant, with contacts
of sham-vaccinated shedders 0 to 0.28 times as likely to remain uninfected as contacts of vacci-
nated (Fisher exact test: 16.82, p< 0.001, odds ratio = 0, 95% CI 0–0.28). However, fewer
infected contacts of vaccinated shedders developed visible disease symptoms or died within 8
weeks (Fig 2A), and of those showing visible symptoms, shedder vaccination was associated with
less severe contact bird symptoms, including fewer tissues with tumours and less severe enlarge-
ment of peripheral nerves, as illustrated by nonmetric multidimensional scaling (Fig 2B).
Infected contacts were much less likely to show visible disease symptoms at necropsy after
contact with vaccinated (232 out of 437 contacts; 53%) than sham-vaccinated (558 out of 569;
98%) shedders (Table 1). Disease symptoms in infected contacts were also more likely in the
20 DPI than 13 DPI contact groups (mixed-model logistic regression: z = 4.5, p< 0.0001), but
this temporal effect was smaller when shedders were sham-vaccinated (vaccination status by
DPI interaction; z = −2.3, p< 0.05). Males were marginally less likely to show visible disease
symptoms than females (z = −1.9, p = 0.05).
Mortality rates were also much lower among infected contacts exposed to vaccinated shed-
ders (Fig 3), with those exposed to sham-vaccinated shedders being 6 times more likely to die
per unit time (95% CI 3.9–8.4; Table 1). Controlling for vaccination effects, contacts exposed
to shedders at 20 DPI were almost twice as likely to die as those exposed to shedders at 13 DPI
(95% CI 1.3–2.1; z = 3.6, p< 0.0005).
Among contacts positive for disease symptoms at necropsy, shedder vaccination led to sig-
nificantly lower disease severity (number of tissues with tumours and enlargement of 3 periph-
eral nerves; see Fig 2B) for all individual symptoms except vagus nerve enlargement (Table 1).
There was no evidence for an increase in contact bird disease severity between shedder DPI 13
and 20 for either vagus nerve (mixed-model ordinal logistic regression: z = −0.1, p = 0.89) or
tumours (z = 1.2, p = 0.21) but marginal evidence for greater brachial nerve enlargement
(z = 1.9, p = 0.06) and a significant increase in sciatic nerve enlargement (z = 3.1, p< 0.005)
associated with the later exposure time. Regardless of the shedder vaccination status and expo-
sure time, disease severity was significantly higher in contact females than males for all symp-
toms (Fig 2B; S1 Table).
Next, we tested the extent to which shedder vaccination status also influenced contact FVL
as an indicator of the infectiousness of contact birds, which has potentially important knock-
on effects for epidemiological dynamics. Infectiousness is likely to be determined by the
amount of virus shed into the environment. Across all individuals, contact bird FVL at 14
DPC was much higher when exposed to sham-vaccinated than vaccinated shedders (Table 1,
Fig 4). Contact FVL was also higher when exposed to shedders at 20 DPI than 13 DPI (mixed-
model linear regression: t = 4.9, p< 0.0001).
In summary, contact birds exposed to vaccinated shedders still became infected but were
considerably less likely to develop disease, experienced milder symptoms and lower mortality,
and had lower FVLs.
Vaccination and the transmission of pathogen virulence
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Fig 2. Summary of shedder impacts on contact birds. (A) Impact of shedder vaccination status on contacts at 13 and 20 shedder DPI.
Contacts positive for virus in qPCR from samples taken at 14 DPC were classified as infected. ‘Diseased’ individuals showed visible
symptoms (peripheral nerve enlargement and/or tumours) at necropsy, 8 weeks post-contact, or upon death. ‘Dead’ contacts were those
that died or were humanely euthanized before the end of the 8-week experimental period, were infected, and were positive for disease
symptoms at necropsy. HVT = vaccinated shedders; PBS = sham-vaccinated shedders. (B) Nonmetric multidimensional scaling plot, for
diseased contacts only, of relationships between contact bird disease severity variables and contact bird sex, shedder vaccination status,
and shedder FVL. Points are individual contact birds. Grey arrow distance along each axis represents its nonparametric Kendall’s tau
correlation with that axis. Opposite-pointing arrows indicate negative associations. Contacts of vaccinated shedders and males therefore
had fewer tumours and less extreme nerve enlargement. Points are clustered from bottom-left to top-right into increasing numbers of
tissues with tumours, concordant with changing point size; clustering in other directions indicates qualitatively different combinations
of tissues with tumours. Variables differ qualitatively (binary, continuous, or ordinal) and so correlation coefficients and hence arrow
Vaccination and the transmission of pathogen virulence
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Shedder vaccination effects on contacts are mediated by FVL
We hypothesized that the effects of shedder vaccination on contacts, described above, were
mediated by a reduction in shedder FVL with vaccination, leading to a reduction in contact
exposure dose with knock-on effects for disease development. To test this hypothesis, we fol-
lowed the protocol for process analysis using regression, outlined in the Statistical Analysis
section of Methods and materials. Before this, we tested whether HVT vaccine transmission
occurred and might contribute to the described downstream effects.
HVT-specific qPCR on peripheral blood lymphocyte (PBL) samples of all contact birds
from 6 contact bird groups (3 groups with 0 contact bird mortality and 3 with high mortality)
revealed that only 8/89 (9%) unvaccinated contact birds were positive for HVT. HVT-positive
birds were evenly distributed across contact groups, with 5/6 groups containing at least 1 posi-
tive bird (1 low-survival group had no positive birds), and no group containing more than 2
positive birds. According to Fisher exact tests, there were no significant differences in propor-
tions positive for HVT between high- and low-survival groups (Fisher exact test: p = 0.71, odds
ratio = 0.59, 95% CI 0.09–3.26). HVT transmission was unexpected given the young age of
shedders and low vaccination dose [39–41] but was nevertheless too low to provide statistically
significant evidence for secondary protective effects impacting contact bird FVL and disease
progression. We therefore did not explicitly consider HVT vaccine transmission in our subse-
quent analyses, while acknowledging the possibility that transmission of undetectably small
quantities of HVT that may enhance the downstream effects of vaccinated shedders may exist.
lengths may not be directly comparable. Shedder DPI effects not shown (see Results text and S1 Table). Underlying data are in
Edinburgh DataShare repository (https://doi.org/10.7488/ds/2725). BNE, brachial nerve enlargement; DPC, days post-contact; DPI, days
post-infection; FVL, feather viral load; HVT, herpesvirus of turkeys; MD, Marek disease; NMS1, nonmetric multidimensional scaling
axis 1; qPCR, quantitative polymerase chain reaction; SNE, sciatic nerve enlargement; VNE, vagus nerve enlargement.
https://doi.org/10.1371/journal.pbio.3000619.g002
Table 1. Effects of shedder vaccination status on contact bird disease symptoms, mortality and FVL for a model also including contact bird sex and shedder DPI,
but excluding DPI by vaccination status interaction. Full results, including models with the interaction, are in S1 Table.
Contact bird response Shedder vaccination coefficient (SE)6 Test statistic7 p-value
Disease status1 8.19 (1.50) 5.45 <0.0001 ���
Mortality2 1.74 (0.20) 8.76 <0.0001 ���
N tissues with tumours3 0.50 (0.13) 3.71 <0.0005 ���
Vagus nerve enlargement4 0.22 (0.23) 0.94 0.35
Brachial nerve enlargement4 1.30 (0.26) 5.01 <0.0001 ���
Sciatic nerve enlargement4 1.30 (0.24) 5.36 <0.0001 ���
FVL5 1.98 (0.11) 18.3 <0.0001 ���
1Infected contacts (qPCR) only. Logistic regression. Coefficient = mean log odds ratio for presence of contact disease symptoms when exposed to sham-vaccinated
relative to vaccinated shedders.
2Infected contacts (qPCR) only. Cox proportional hazards. Coefficient = log hazard ratio of contact death at a given time point associated with sham-vaccinated relative
to vaccinated shedders.
3Diseased contacts (necropsy) only. Poisson GLM. Coefficient = mean difference in number of contact tissues containing tumours with sham-vaccination.
4Diseased contacts (necropsy) only. Ordinal logistic regression. Coefficient = proportional log odds of an increase in contact nerve enlargement ranking with sham-
vaccination.
5All contacts. Least square mean difference in contact bird log10(viral load + 1 × 10−5) with sham-vaccinated relative to vaccinated shedders.
6Positive = increase in contacts when exposed to sham-vaccinated relative to vaccinated shedders, except for FVL (>1 = increase with sham-vaccination).
7t statistic for linear regression, z statistic for all other models.
Abbreviations: DPI, days post-infection; FVL, feather viral load; GLM, generalized linear model; qPCR, quantitative polymerase chain reaction; SE, standard error.
https://doi.org/10.1371/journal.pbio.3000619.t001
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Sham-vaccinated shedders had much higher FVL than vaccinated (mixed-model linear
regression: t = 13.35, p< 0.0001; Fig 4). There was a highly significant increase in shedder
FVL at 20 DPI over 13 DPI (t = 7.49, p< 0.0001), but the highly significant interaction
between vaccination status and DPI (t = −5.03, p< 0.0001) revealed that this temporal change
only occurred in vaccinated shedders.
Replacing shedder vaccination status with shedder FVL as a covariate in the statistical
models for contact birds revealed that the effects of shedder FVL on contacts followed the
same pattern as the effects of shedder vaccination status. Higher shedder FVL led to a small
but significant increase in contact bird infection probability (univariate logistic regression: log
odds = 0.76, z = 3.0, p< 0.005), with predicted infection probability increasing from 0.946 at
Fig 3. Cox proportional hazards estimated survival probability curves for all combinations of shedder vaccination status and DPI. Shaded areas
represent 95% confidence intervals. HVT = vaccinated shedders; PBS = sham-vaccinated shedders. Note that all mortality up to 7 DPC was assumed to
be chick mortality unrelated to MD, and these individuals were excluded from all analyses. Underlying data are in Edinburgh DataShare repository
(https://doi.org/10.7488/ds/2725). DPI, days post-infection; DPC, days post-contact; HVT, herpesvirus of turkeys; MD, Marek disease.
https://doi.org/10.1371/journal.pbio.3000619.g003
Vaccination and the transmission of pathogen virulence
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the lowest shedder FVL values to 0.997 at the highest. Higher shedder FVL led to greater con-
tact bird disease prevalence and severity, greater mortality, and higher contact FVL (Table 2).
Including shedder FVL in a model alongside vaccination status reduced but did not always
remove the significance of vaccination status for all contact bird disease variables (S1 Table).
This indicated that shedder FVL at least partially explained the impacts of shedder vaccination
on infected contacts. However, the further addition of contact FVL and sum of contact group-
mate FVL (the latter to account for possible among-contact infection during the 8-week exper-
imental period) as predictors fully explained the effects of shedder vaccination on contact
disease and survival, rendering shedder vaccination status nonsignificant in all models (Fig 5).
The results indicate that shedder vaccination effects on contacts are fully mediated by FVL of
shedders and infected contacts.
Fig 4. Box and whisker plot of shedder and contact FVLs at 13 and 20 DPI. Horizontal bars are medians. Boxes cover the first to third quartile, and
vertical lines extend to maxima and minima except in the presence of outliers (filled circles). Shedder feather samples were taken at the start of each
contact period, contact samples at 14 DPC. A small value (1 × 10−5) was added to FVL values prior to log transformation, and hence the log10(viral load)
for birds negative for virus was −5. Underlying data are in Edinburgh DataShare repository (https://doi.org/10.7488/ds/2725). DPC, days post-contact;
DPI, days post-infection; FVL, feather viral load.
https://doi.org/10.1371/journal.pbio.3000619.g004
Vaccination and the transmission of pathogen virulence
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Table 2. Effects of shedder FVL on contact bird disease symptoms and feather viral load, for a model also including contact sex and shedder DPI but not including
shedder vaccination status. Full results in S1 Table.
Contact bird response Shedder viral load slope (SE) Test statistic6 p-value
Disease status1 3.83 (0.62) 6.17 <0.0001 ���
Mortality2 0.93 (0.11) 8.76 <0.0001 ���
N tissues with tumours3 0.34 (0.09) 3.57 <0.0005 ���
Vagus nerve4 0.24 (0.16) 1.51 0.13
Brachial nerve4 0.91 (0.17) 5.4 <0.0001 ���
Sciatic nerve4 0.90 (0.16) 5.57 <0.0001 ���
Feather viral load5 0.83 (0.08) 10.33 <0.0001 ���
1Infected contacts (qPCR) only. Logistic regression. Coefficient = increase in log odds ratio for presence of contact disease symptoms with 1 unit increase in shedder
FVL.
2Infected contacts (qPCR) only. Cox proportional hazards. Coefficient = increase in log hazard ratio of contact death at a given time point with 1 unit increase in
shedder FVL.
3Diseased contacts (necropsy) only. Poisson GLM. Coefficient = increase in number of contact tissues containing tumours with 1 unit increase in shedder FVL.
4Diseased contacts (necropsy) only. Ordinal logistic regression. Coefficient = increase in proportional log odds of contact nerve enlargement ranking with 1 unit
increase in shedder FVL.
5All contacts. Increase in contact FVL with 1 unit increase in shedder FVL.
6t statistic for linear regression, z statistic for all other models.
Abbreivations: DPI, days post-infection; FVL, feather viral load; GLM, generalized linear model; qPCR, quantitative polymerase chain reaction; SE, standard error
https://doi.org/10.1371/journal.pbio.3000619.t002
Fig 5. Diagrammatic representation of the mediating effects of viral load on contact bird binary disease status.
Each arrow colour represents a different multiple regression analysis, with arrows pointing from predictors to
response. Arrow thickness represents regression coefficient (all significant or marginal relationships were positive).
The diagram shows that the effect of shedder FVL on contact FVL (see Table 2) fails to fully explain the shedder
vaccination effect, which remains significant when both variables are included (purple arrows). The same is true for
the cumulative FVL of all infected groupmates (yellow arrows). However, the 3 FVL predictor variables together
completely remove the effect of shedder vaccination status (blue arrows) in explaining contact disease status (see
Table 1), and this is true for all other contact disease variables (S1 Table). This implies that shedder vaccination effects
on contacts are fully mediated by FVL of infected individuals in a contact group. Significance is indicated by asterisks:
���p< 0.001, ��p< 0.01, �p< 0.05, ns = not significant. Marginally nonsignificant p-values are presented numerically.
All results presented here are from models excluding the DPI by vaccination status interaction but including sex and
DPI main effects (not shown, see S1 Table). Underlying data are in Edinburgh DataShare repository (https://doi.org/
10.7488/ds/2725). DPI, days post-infection; FVL, feather viral load.
https://doi.org/10.1371/journal.pbio.3000619.g005
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To examine whether the presence of even undetectably small quantities of vaccine virus in
contact birds might affect the causal relationship between same-individual viral load and dis-
ease development, we carried out further multiple regression analyses, with contact bird patho-
gen FVL nested within shedder vaccination treatment. As expected in the absence of any extra
effect of vaccine transmission, contact FVL remained significant within each vaccination treat-
ment (except for vagus nerve, which was nonsignificant in results presented in Tables 1 and 2),
with similar effect size estimates in each (S1 Table).
Discussion
We used controlled experiments involving natural virus transmission to reveal that vaccina-
tion with a leaky vaccine, which only marginally reduces transmission, can significantly reduce
post-transmission disease development and mortality among unvaccinated contact individu-
als. Our analysis indicates that this effect is mediated by a reduction in exposure dose experi-
enced by susceptible individuals when exposed to vaccinated shedders, leading to lower
pathogen load and concomitant reduced symptoms in contact birds. The primary objectives
of vaccination of livestock with leaky vaccines are to improve animal welfare and to reduce
production losses caused by disease symptom development. Our results show that even partial
vaccination against MD can substantially reduce disease symptoms and mortality in the whole
flock, leading to universally positive impacts on animal welfare and productivity, and these
conclusions may extend to leaky vaccines used in other systems.
Modified live virus vaccines, such as HVT and other MD vaccines, have the potential to
be transmitted and cause secondary vaccination [37–41], and this may partially explain our
results. Unlike in previous studies, showing that HVT transmission only occurred from older
birds vaccinated with higher doses [39–41], we found nonzero transmission of HVT from
young birds vaccinated with a low dose. However, with HVT virus absent or below detectable
levels in 91% of contacts of vaccinated shedders, HVT transmission would fail to explain the
reduced contact bird MDV viral load and disease progression in our statistical analyses. We
found that shedder FVL, as a proxy of exposure dose, did not always fully explain the shedder
vaccination effects on contact birds. This may be because feather samples taken at the start of
a 48-hour contact period provide an imperfect proxy for exposure dose. It may also be partly
due to the presence of another factor, such as vaccine transmission, further influencing both
contact bird viral load and disease progression and their associations. However, contact bird
FVL strongly and equally explained disease progression in contacts of each of vaccinated and
unvaccinated shedders, suggesting no additional factors influencing this relationship in the
vaccinated treatment. Vaccine transmission nevertheless remains potentially important and
should be addressed in future studies, for both MDV and other diseases treated with transmis-
sible vaccines.
One of the key findings of this study was that shedder vaccination effects on MD symptom
prevalence and subsequent mortality within each contact group were fully explained by the
summed FVL of all infected group members, measured at a relatively early stage of the epi-
demic, prior to onset of contact-contact transmission. This would suggest that contacts
exposed to vaccinated shedders experienced overall lower cumulative exposure dose, including
from other infected contacts, over the course of 8 weeks, resulting in milder symptoms and
lower mortality. This negative feedback on the environmental pathogen burden strongly advo-
cates for the application of MD intervention strategies that reduce either within-host or envi-
ronmental virus load, even if only moderately [47]. In general, depending on the relationship
between exposure dose and subsequent within-host replication in any particular system,
Vaccination and the transmission of pathogen virulence
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targeting reduction in pathogen load in intervention strategies may have greater positive
knock-on effects than currently assumed.
Increased disease severity with higher virus inoculation dose has been shown previously
for MD in chickens [27,30] but not with natural transmission and not linked to interventions
such as vaccination. The route of infection is known to alter the extent of infection and num-
ber of diseased tissues [48]; hence it is important to mimic the field situation closely in order
to accurately predict the outcome of vaccination and other intervention strategies in this and
other systems. It is also important to measure pathogen load specifically in the infectious tis-
sues where possible, or to measure shedding directly, because tissues may differ in the strength
of association between their pathogen load and infectiousness. Vaccine experiments routinely
establish the protective effect of vaccination on infection or disease progression, and pathogen
shedding, in vaccinated individuals themselves [49], and occasionally also examine onward
transmission. The novelty and primary focus of this study was to determine the effects of vacci-
nation of ‘shedder’ individuals on disease progression and infectiousness specifically in newly
infected, unvaccinated, contact individuals. To date, little is known about these potential
‘downstream’ effects of vaccination, and the majority of epidemiological models that predict
the consequences of vaccination on disease spread and pathogen evolution assume that these
do not exist [3,50]. Our findings that vaccination affects downstream pathogen load and host
survival and hence, potentially, onward pathogen transmission, in a dose-dependent manner
may have profound consequences for such predictions. Particularly in systems in which an
individual’s infectiousness is strongly influenced by its pathogen load, existing estimates of the
required vaccine coverage for achieving so-called herd immunity, i.e., for preventing disease
spread within a population, may be upwardly biased. Based on current estimates, herd immu-
nity is assumed to require high coverage when vaccines are leaky [18,51]. Complete vaccine
coverage is not typical for all infectious diseases throughout the world, and, even where it is
routine, vaccine administration can vary in quality. Furthermore, high variation in vaccine
responsiveness may render a significant proportion of vaccinated animals effectively nonim-
munized [52]. The results of our study suggest that partial vaccination or high prevalence of
vaccine non-responders may impose less risk with respect to disease invasion and persistence
than anticipated from existing theory [4,53,54]. Prediction of the coverage required for herd
immunity would benefit from an understanding of the downstream effects of vaccination-
induced changes in exposure dose and their effects on individuals’ infectiousness and survival
in any particular system. These insights would also be useful for the development of dynamic
epidemiological models that incorporate dose-dependent transmission effects and the impact
of interventions on these [19,24,55–57].
Vaccination with leaky vaccines has been implicated in the evolution of increased pathogen
virulence, primarily because vaccination reduces host mortality without preventing pathogen
transmission, allowing vaccinated infectious hosts more time to transmit virulent pathogen
strains [3,5,50]. This reduced mortality with vaccination, when combined with higher shed-
ding rate in more virulent strains (as has been found for MDV [5,58]), shifts the balance
between transmission and host mortality in favour of higher virulence [58]. The best evidence
for this vaccination effect on virulence evolution comes from studies of MDV [5]. Our results,
showing that vaccination can also reduce mortality in unvaccinated contact individuals with-
out strongly affecting transmission rates, indicate that virulence could evolve to higher levels
than previously expected in a mixed flock. However, this expectation is specific to this particu-
lar combination of pathogen, vaccine and host strain, and depends on the relationship between
vaccination and shedding rate. Previous studies have shown that the shedding rate of more vir-
ulent MDV strains is less affected by vaccination [5,59], further favouring their transmission,
and this effect is thought to promote increased pathogen virulence in a rodent malaria system
Vaccination and the transmission of pathogen virulence
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[60,61]. However, in a system such as ours in which exposure dose is important, a smaller vac-
cine effect in reducing shedding of more virulent strains may not necessarily favour higher vir-
ulence in mixed flocks because of the resulting higher exposure dose and consequent
increased downstream mortality. Further modelling is required to predict virulence evolution
in mixed flocks in the presence of the downstream impacts presented here, and the differential
effects of vaccination on viral shedding rate reported elsewhere. Furthermore, the lower patho-
gen load and slightly reduced rate of spread revealed here—the latter effect potentially being
stronger in other systems—would lower the effective population size of the virus, therefore
lowering the probability of establishment and fixation of new beneficial mutations such as
those increasing virulence [62]. This may partially explain why years pass between reported
increases in MDV virulence, despite 59 billion chickens being reared annually worldwide
[34,63]. The results of this study therefore suggest that existing models of virulence evolution
would benefit from incorporation of dose response effects on downstream disease severity and
mortality such as those detected here.
Vaccination is often not the only available intervention technique, and others such as
improved animal husbandry techniques or genomic selection of genetically more resistant
individuals [64–66] may also be available and cost-effective. The mediating effect of pathogen
load can be used as a link for comparison between the effects of different interventions on
pathogen dynamics and disease severity. Chickens are known to vary genetically in their resis-
tance to MD [64], and hence a next step in understanding the benefits of interventions in this
system would be to compare vaccination effects with host genetic effects. Furthermore, more
virulent virus strains tend to result in higher viral shedding rates and may differ in their
response to vaccination [5]. Hence, future studies to test the validity of our findings for multi-
ple MDV and vaccine strains are warranted.
With the increasing development of leaky vaccines for treatment of human as well as
livestock infectious diseases [3], there is great benefit in improving prediction of their con-
sequences for host welfare, pathogen dynamics, and virulence evolution. The currently
neglected downstream, post-transmission effects we revealed in this study are likely to
impact all of these important facets of infectious disease biology and hence disease man-
agement strategies. They therefore merit greater attention in future vaccine-related
studies.
Methods and materials
Ethics statement
All bird experiments were approved by the Avian Disease and Oncology Laboratory IACUC,
US National Poultry Research Center, United States Department of Agriculture, approval
number: Avian Disease and Oncology Laboratory (ADOL) 2016–07. Our animal care and use
protocol adhered to the Animal Welfare Act (AWA), United States Department of Agriculture
(USDA), and Animal Plant Health Inspection Service (APHIS). All experiments were carried
out in custom-made negative pressure Horsfall-Bauer isolators [67]. A scoring system was
developed and approved by the ADOL IACUC for monitoring progression of MD and for
determining humane endpoints (SOP #9). Humane endpoint criteria include body posture,
neurological signs, eye closure, response to stimuli, and ability to eat and drink. Chickens
experiencing clinical signs of MD were immediately humanely euthanized upon reaching the
prescribed clinical sign score. The euthanasia method was carbon dioxide gas inhalation,
based on AVMA Guidelines for the Euthanasia of Animals 2020.
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Transmission experiments
Experiments were carried out at USDA, ARS, USNPRC, ADOL, East Lansing, USA, during
2018. All experiments used 15I5 × 71 white leghorn chickens, a F1 hybrid cross of MD-
susceptible 15I5 males and 71 females [43]. These maternal antibody-negative chickens were
reared from a SPF breeding flock housed in isolators that have received no MD vaccination or
exposure. The flock was negative for MDV antibodies and also for exogenous avian leukosis
virus and reticuloendotheliosis virus, as established by routine surveillance testing.
The experiments involved 2 types of shedders, with shedder birds either vaccinated at hatch
via intra-abdominal (IA) inoculation with 2,000 PFU of HVT (Meleagrid alphaherpesvirus 1)
[33] or sham-vaccinated with PBS. Each shedder bird was then challenged with 500 PFU of
virulent MDV (strain JM/102W) at 5 DPV (0 DPI). Each contact group of birds within each
replicate consisted of 3 shedder birds of the same vaccination treatment (HVT or PBS) to be
placed in contact with 15 unvaccinated, uninfected contacts (Fig 1). The 3 shedders were
placed with the first group of 15 uninfected contacts at 13 DPI for 48 hours before being
removed back to their isolator at 15 DPI. They were then placed with a second group of 15
contacts at 20 DPI until 22 DPI. Contact chicks were hatched weekly so that all contact birds
were within 4 days of age when shedders were first introduced. There were 16 replicates con-
sisting of paired lots of shedder birds (1 lot with 3 vaccinated shedders put into contact with 15
contacts at the 2 time points and the other with 3 sham-vaccinated shedders) and 4 further
sham-vaccinated only replicates. These additional replicates were carried out because of early
death of 2 sham-vaccinated shedders involved in the earlier replicates.
Shedders were then monitored until 8 weeks post-infection and contacts until 8 weeks
post-contact and mortality (death or euthanasia) recorded. Necropsy was carried out at 8
weeks or upon death, whichever was the sooner, to determine the presence and severity of MD
symptoms.
Blood (100 μl) and primary feather samples were taken from shedders at the start of each
contact period (13 and 20 DPI) and from contacts at 14 DPC. Based on earlier experiments, 14
DPC was sufficient for build-up of virus in blood and feathers but early enough to avoid cross-
contamination from other contact birds (S4 Text, S4 Fig). If HVT vaccine virus transmission
occurred, 14 days would also be sufficient for HVT to replicate to close to its maximum viral
load in the new host [36–38,68]. DNA samples isolated from feather pulp and PBLs were used
for qPCR to determine virus load. Each measurement was taken from a unique sample.
DNA from each tissue type was isolated using the Puregene DNA isolation kit (Gentra Sys-
tem, Minneapolis, MN) followed by a multiplex PCR using methods as previously described
for MDV [69] and HVT [70]. The TaqMan assay used FAM-TAM probes for virus gB and
VIC-TAM probes for the cellular GAPDH. Results were reported as the ratio of virus gB copies
per GAPDH copies, estimated using standard curves consisting of 10-fold serial dilutions of
plasmids containing either virus gB or GAPDH. Amplifications were performed at Michigan
State University, USA, using the ABI Quant Studio 7Flex BI 7500 (Carlsbad, California).
Statistical analyses
At total of 42 of 1,080 contacts were removed from the data set prior to analysis because of
chick mortality (death up to 7 days old), with some further filtering for data quality and death
by other causes. Final sample sizes were 211 (shedder FVL as response), 1,005 (infected con-
tacts only), 789 (diseased contacts only), and 1,023 (all contacts regardless of infection or dis-
ease status). The transmission experiments were analysed using various linear and generalized
linear mixed models in R version 3.6.0 [71], depending on the type of the response variable
(Table 3). Regression analyses followed the logic of process analysis [72] to assess the role of
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pathogen load in mediating shedder vaccination effects on contacts—details below. Nonmetric
multidimensional scaling for Fig 2B was carried out in PC-ORD version 7.0 [73] statistical
software. All statistical tests were two-sided. No adjustments were made for multiple
comparisons.
First, we tested the direct treatment effect (shedder vaccination status) on the outcome
variables (contact disease variables, Table 3). The model formulae also included as fixed effects
contact bird sex and shedder DPI, and a vaccination status by DPI interaction, which was
removed if nonsignificant. Replicate and contact group nested within replicate were included
as random effects in all models except for the survival analysis, for which contact group and
replicate were included as clustering variables. Each contact individual was treated as a data
point. For this and all subsequent analyses, testing contact FVL as response involved all contact
individuals, infected or uninfected (Table 3). Contact binary disease status and mortality anal-
yses involved infected (from qPCR) contacts only, and disease severity variables (tumours and
nerve enlargement) involved diseased (from necropsy) contacts only.
Second, we carried out a process analysis, for which we tested all intermediate steps in the
following proposed causal chain (see Fig 5): We hypothesized that the impacts of shedder vac-
cination status on the various contact infection and disease variables were primarily mediated
by the vaccine effect on shedder FVL. More specifically, we hypothesized that shedder vaccina-
tion directly reduces shedder FVL and consequently also the exposure dose of contacts. The
resulting lower exposure dose may reduce the probability of becoming infected and/or may
lead to lower ingestion dose and consequently also to lower viral load in infected contacts.
Lower contact viral load reduces the probability in infected contacts of developing visible dis-
ease symptoms or dying within the 8-week experimental period and also reduces disease sever-
ity among individuals positive for symptoms at necropsy. Eight weeks is also sufficient time
for infected contacts to become infectious themselves and for disease development to occur in
contacts infected by other contacts. Hence it was necessary to also consider the FVL of infected
group mates alongside shedder and contact FVL in the process analysis.
Table 3. Summary of modelled response variables.
Response variable Description Source Coefficient interpretation Statistical model Data
subset6
Disease status Binary presence/absence of visible disease
symptoms
Necropsy Log odds Logistic regression (GLM binomial
errors)1
Infected
Mortality Day of death/euthanasia or last day of study Daily
observations
Log proportional hazard
ratio
Right-censored Cox proportional
hazards2
Infected
N tissues with
tumours
Number of tissues with visible tumours Necropsy Log relative risk GLM Poisson errors3 Diseased
Nerve enlargement Qualitative ranking of nerve enlargement
(0–4)
Necropsy Log proportional odds Ordinal logistic regression4 Diseased
Viral load log10(Ratio of virus to GAPDH quantity
+ 1 × 10−5)
qPCR Mean relative quantity Ordinary linear regression5 All
1R function glmer in lme4 package [74]; logit link.
2R function coxph in survival package [75].
3R function glmer in lme4 package; log link.
4R function clmm in ordinal package [76]; logit link.
5R function lmer in lme4 package; identity link.
6Infected = positive for virus in qPCR of one or both of feather and blood samples; Diseased = presence of visible disease symptoms (tumours and/or peripheral nerve
enlargement) at necropsy; All = all contact individuals including uninfected.
Abbreviations: GAPDH, Glyceraldehyde 3-phosphate dehydrogenase gene; GLM, generalized linear model; qPCR, quantitative polymerase chain reaction
https://doi.org/10.1371/journal.pbio.3000619.t003
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Transmission of HVT was nonzero but nevertheless too low in a subsample of 6 contact
bird groups to explain the vaccination effect (see Results section) and was therefore not explic-
itly included in our process analysis. We began the process analysis by testing whether shedder
FVL explained a similar amount of contact bird disease variation as shedder vaccination status,
by replacing shedder vaccination status with shedder FVL in the model formula described in
the first step above. We then tested to what extent shedder FVL was affected by vaccination
and then to what extent contact FVL and the sum FVL of each contact bird’s groupmates
(hereafter denoted as groupmate FVL) were affected by vaccination and shedder FVL. Thus,
for contact FVL and groupmate FVL as response variables, the model formulae were the same
as described in the first step above, with the addition of sum of shedder FVL for each contact
group as a fixed effect. Conversely, when shedder FVL was tested as a response variable, we
used each individual shedder feather sample as a data point, and hence there were 2 data points
per shedder individual (13 and 20 DPI). For this test, we used the same fixed effects model for-
mula as described in the first step above, while replicate and shedder individual were included
as random effects, the latter to account for repeated measures.
The values for contact FVL at 14 DPC were calculated as log10(contact FVL + 1 × 10−5) for
each individual. The contact groupmate FVL variable was the sum of FVL at 14 DPC of all 15
contacts in a group, minus the value for the focal individual. This variable was also analysed as
log10(groupmate FVL + 1 × 10−5). For shedder FVL as a predictor, we calculated log10(sum
(shedder FVL + 1 × 10−5)) across the 3 shedders, from feather samples collected at the start of
the contact period with each group of 15 contacts (13 and 20 DPI).
Third and finally, we tested whether shedder vaccination status exerted any effect on con-
tact disease variables when controlling for mediating effects (shedder, contact, and contact
groupmate FVL). If shedder vaccination status were to be rendered nonsignificant when tested
alongside FVL variables, this would support the hypothesis that shedder vaccination impacts
on contact disease were fully mediated by their effects on FVL. We first added shedder FVL
alone to the basic model described in step 1, above, to test whether this variable was an effective
bioindicator of shedder vaccination effects in secondary cases (infected contacts). We then fur-
ther added contact and groupmate FVL to the model. Same-individual viral load is expected to
be the strongest indicator of disease status, and so we expected shedder vaccination status and
shedder and groupmate FVL to become nonsignificant in this model.
To examine whether the presence of even undetectably small quantities of vaccine virus in
contact birds might affect the causal relationship between same-individual viral load and dis-
ease development, we carried out further multiple regression analyses with contact FVL nested
within shedder vaccination treatment. For each response variable, we used a mixed-effects
model with the same random effects as described above, and fixed effect predictors shedder vac-
cination status, shedder DPI, and contact bird sex alongside the nested contact FVL predictor.
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S4 Text. Determination of appropriate sampling time post-contact for measuring FVL in
contact birds. FVL, feather viral load.
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S1 Fig. Effects of exposure duration on contact bird MD. For each tested contact duration,
the proportion of line 15I5 × 71 F1 contact birds positive for MD symptoms at necropsy, 8
weeks post-contact with inoculated unvaccinated ‘MD-resistant’ line 6 (blue line) or ‘MD-sus-
ceptible’ line 7 (red line) shedder birds. MD, Marek disease.
(TIF)
S2 Fig. FVL over time for shedder birds. Vaccinated (blue) and sham-vaccinated (red) shed-
ders, with maximum likelihood broken stick regression lines indicating lower viral load and a
later breakpoint in viral load over time for vaccinated shedders. Open circles = replicate 1,
crosses = replicate 2. The shaded area encompasses the set of shedder DPI during which con-
tact occurred between shedders and contact birds. DPI, days post-infection; FVL, feather viral
load.
(TIF)
S3 Fig. Impact of shedder vaccination status and DPI on contact bird infection, disease
symptoms, and mortality. Contacts positive for virus in qPCR from samples taken at 14 DPC
were classified as infected. ‘Diseased’ individuals showed visible symptoms (peripheral nerve
enlargement and/or tumours) at necropsy, 8 weeks post-contact or upon death. ‘Dead’ individ-
uals died because of MD prior to the end of the 8-week experimental period. HVT = contacts
exposed to vaccinated shedders; PBS = contacts exposed to sham-vaccinated shedders. The 2
replicates were pooled for this figure. DPC, days post-contact; DPI, days post-infection; HVT,
herpesvirus of turkeys; MD, Marek disease; qPCR, quantitative polymerase chain reaction.
(TIF)
S4 Fig. Effect of number of days post-contact on contact bird FVL. Histogram of contact
bird FVL from qPCR at 7 (red bars) and 14 (blue bars) days post-contact with unvaccinated
infectious shedders (2 replicates and all 4 shedder chicken lines combined). A value of −5 indi-
cates negative for MDV; i.e., values were below the level of detection by standard qPCR. FVL,
feather viral load; MDV, Marek disease virus; qPCR, quantitative polymerase chain reaction.
(TIF)
S1 Table.
(XLSX)
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